Trade

with

Response Genetics Inc
(NASDAQ: RGDX)
AdChoices
=
0.5410
0.0000
0.00%
After Hours :
-
-
-

Open

0.5501

Previous Close

0.5410

Volume (Avg)

76.62k (93.58k)

Day's Range

0.5410-0.5800

52Wk Range

0.5133-2.22

Market Cap.

20.95M

Dividend Rate ( Yield )

-

Beta

0.68

Shares Outstanding

38.73M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 19.80M

    • Net Income

    • -8.02M

    • Market Cap.

    • 20.95M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -73.61

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.68

    • Forward P/E

    • -

    • Price/Sales

    • 1.16

    • Price/Book Value

    • 4.18

    • Price/Cash flow

    • -2.31

      • EBITDA

      • -7.30M

      • Return on Capital %

      • -91.91

      • Return on Equity %

      • -284.45

      • Return on Assets %

      • -91.91

      • Book Value/Share

      • 0.13

      • Shares Outstanding

      • 38.73M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 2.60

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -19.40

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 22.68

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 39.91

            • 42.70

            • Pre-Tax Margin

            • -73.61

            • 11.63

            • Net Profit Margin

            • -73.61

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 45.50

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -46.40

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -46.40

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.32

              • 0.62

              • Current Ratio

              • 1.75

              • 1.23

              • Quick Ratio

              • 1.54

              • 0.76

              • Interest Coverage

              • -125.65

              • 5.98

              • Leverage Ratio

              • 2.44

              • 2.16

              • Book Value/Share

              • 0.13

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.83

                • 32.15

                • P/E Ratio 5-Year High

                • -9.82

                • 325.07

                • P/E Ratio 5-Year Low

                • -1.49

                • 154.73

                • Price/Sales Ratio

                • 1.35

                • 2.24

                • Price/Book Value

                • 4.87

                • 2.92

                • Price/Cash Flow Ratio

                • -2.31

                • 18.35

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -284.45

                    (-)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -91.91

                    (-58.40)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -209.00

                    (-)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • -

                  • 5.07

                  • Asset Turnover

                  • 1.25

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -7.95M
                  Operating Margin
                  -40.13
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.31
                  Ownership

                  Institutional Ownership

                  53.66%

                  Top 10 Institutions

                  53.17%

                  Mutual Fund Ownership

                  1.95%

                  Float

                  66.77%

                  5% / Insider Ownership

                  12.90%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    460,766

                  • 0.00

                  • 1.19

                  • Vanguard Extended Market Index Fund

                  •  

                    145,825

                  • 0.00

                  • 0.38

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    92,898

                  • 0.00

                  • 0.24

                  • Vanguard Balanced Index Fund

                  •  

                    43,900

                  • -1.35

                  • 0.11

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    6,802

                  • 0.00

                  • 0.02

                  • Wilshire Micro-Cap ETF

                  •  

                    6,667

                  • 0.00

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Bridger Management LLC

                  •  

                    6,000,000

                  • 0.00%

                  • 15.49

                  • Lansdowne Partners Limited Partnership

                  •  

                    3,805,161

                  • 0.00%

                  • 9.82

                  • 12 West Capital Management LP

                  •  

                    2,447,617

                  • 0.00%

                  • 6.32

                  • Awm Investment Company Inc

                  •  

                    2,319,879

                  • -13.41%

                  • 5.99

                  • SRB MANAGEMENT, L.P.

                  •  

                    1,247,794

                  • -38.32%

                  • 3.22

                  • Vanguard Group, Inc.

                  •  

                    651,091

                  • 0.00%

                  • 1.68

                  • Geode Capital Management, LLC

                  •  

                    99,700

                  • +564.53%

                  • 0.26

                  • Goldman, Sachs & Co.

                  •  

                    70,411

                  • +100.46%

                  • 0.18

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Slow Growth

                  Style

                  Small Value

                  Response Genetics Inc was incorporated in the State of Delaware on September 23, 1999. It is a life sciences company engaged in the research and development of clinical diagnostic tests for cancer. The Company currently generates rev...moreenues mainly from sales of its ResponseDX diagnostic tests, which it launched in 2008 and by providing clinical trial testing services to pharmaceutical companies. It has developed technologies for the extraction of RNA from FFPE tissues which enable it to reliably recover RNA suitable for a variety of applications, such as gene expression research, development of diagnostics, and microarray platforms. In addition, its technologies permit gene profiling analysis of current clinical trials, of which use the paraffin embedding technique for tissue specimen storage. The Com...morepany developed and patented extraction methodologies that allow reliable and consistent isolation of RNA and DNA from FFPE suitable for use in various types of analysis. The Company validated its methodology, which particularly addressed issues of recovery of RNA, accuracy, and precision. Further, its methodologies allow for rapid extraction of RNA with little or no DNA contamination, which makes it suitable for large-scale analysis. The Company developed ResponseDX in part by using its technology to extract genetic information from FFPE tumor specimens. Its technology provides gene expression information for each patient’s tumor tissue specimen. It has developed assays for the targets comprising the ResponseDX profiles for use in its CLIA lab. Assay development of these tests was done through appropriate validation procedures which determine the accuracy of each test. The Company offers ResponseDX testing services nationwide. Its main sales include community based oncologists, pathologists, physician offices and hospitals. The Company’s actual competitors in the United States and abroad may include clinical and pathology laboratories, such as Quest Diagnostics Inc., Laboratory Corporation of America, Clarient, Inc. (acquired by GE), and laboratories such as Genoptixs Inc. (acquired by Novartis Pharmaceuticals), NeoGenomics, Inc., Caris Life Sciences, Foundation Medicine, university laboratories and other research institutions. The Company is subject to various regulatory requirements designed to ensure the quality and integrity of its non-clinical testing processes. Its business is also subject to regulation under state and federal laws regarding environmental protection and hazardous substances control, such as the Federal Occupational Safety and Health Act, the Environmental Protection Act, and Toxic Substances Control Act.lessless

                  Key People

                  Mr. Thomas A. Bologna

                  CEO/Chairman of the Board/Director

                  Kevin R. Harris

                  CFO/Chief Accounting Officer/Vice President

                  Stephanie H. Astrow

                  Vice President, Divisional

                  David R. Schreiber

                  Director

                  Mr. Kirk K. Calhoun

                  Director

                  • Response Genetics Inc

                  • 1640 Marengo Street

                  • Los Angeles, CA 90033

                  • USA.Map

                  • Phone: +1 323 224-3900

                  • Fax: +1 323 224-3096

                  • responsegenetics.com

                  Incorporated

                  1999

                  Employees

                  113

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: